Arvaya Healthcare Board to Consider Rights Issue and Related Party Transactions
Bijoy Hans Ltd 路 Intimation 路 29 Oct 2026, 10:38 pm
Arvaya Healthcare Board to Consider Rights Issue and Related Party Transactions Arvaya Healthcare Limited's Board of Directors is scheduled to meet on 4th Nov'26 to review and approve key capital and corporate actions. The agenda includes evaluating the Draft Letter of Offer (DLOF) for its proposed Rights Issue, finalizing the issue's objects, and determining the deployment and utilization of proceeds. Additionally, the board will consider and approve proposed material related-party transactions, subject to required Audit Committee recommendations and shareholder approvals.
Original exchange filing (PDF)
More announcements from Bijoy Hans Ltd
- The investor call arranged by the company on 16th November,2026 was concluded successfully. Please find attached herewith Audio for the same. 路 17 Nov 2026
- Investor Presentation in relation with the Unaudited Standalone and consolidated Financial Results of the Company for the quarter and half year ended on September 30 2026 and overall company .... 路 16 Nov 2026
- Unaudited Standalone and Consolidated financial results for the quarter ended 30th September 2026 路 14 Nov 2026
- Statement of Deviation and Variation for the quarter ended 30th September 2026 is not applicable to the Company. 路 14 Nov 2026
- Declaration of Unaudited standalone and consolidated Financial Results for the half year ended and 2nd quarter ended 30th September 2026 路 14 Nov 2026
- Revision in intimation and In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Arvaya Healthcare Limited (formerly known .... 路 16 Nov 2026
- In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Arvaya Healthcare Limited (formerly known as Bijoy Hans Limited) (''the .... 路 16 Nov 2026
- Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Pursuant to the provisions .... 路 13 Nov 2026
